Novartis UK is pleased to invite you to the upcoming webinar...

Severe Asthma Masterclass:

Optimising severe asthma care in 2021

22nd March 2021

19:00 - 20:45

This promotional meeting is organised and funded by Novartis Pharmaceuticals UK Limited.

UK | February 2021 | 105572

Adverse events should be reported. Reporting forms and information can be found at  www.mhra.gov.UK/yellowcard (UK).

Adverse events should also be reported to Novartis via  uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at  www.report.novartis.com

If you have a question about a product, please contact Medical Information on 01276 698370 or by email at  medinfo.uk@novartis.com

To learn about your data privacy rights and the use of your personal information, we invite you to read our General Privacy Notice for Business Partners.